首页> 中文期刊> 《临床医药实践》 >我院临床使用血液制品情况分析

我院临床使用血液制品情况分析

         

摘要

Objective:To summery some nearly five years of clinical use of blood products,provide the basis for blood col-lection and management. Methods:To compare the clinical blood,department blood and rate of component blood transfusion from January 2009 to December 2013 Results:Total and partial use of blood products haven't changed much,composition blood transfusion rate was 99. 1%. To compare department blood,surgical department was the most. Blood transfusion indications co-incidence rate was 93. 5%,the blood transfusion adverse reaction rate was 1. 1%. Conclusion:Situation has gradually towards standardization of clini cal blood use. But still need to strengthen the management of blood products and use of the work.%目的:总结近5年临床使用血液制品情况,为用血管理提供依据。方法:对2009年1月-2013年12月临床用血情况和科室用血结果及成分输血率进行比较。结果:全院血液制品使用总量变化不大,成分输血率在99.1%左右,科室用血量比较,以普外科用血最多。输血指证符合率为93.5%,输血不良反应率为1.1%。结论:临床用血情况已逐步走向正规化,但仍需加强血液制品的管理和使用工作。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号